Noiruimunbaiotekku

4893.TTSE GROWTHPharmaceutical
Filed as Noile-Immune Biotech Inc. (2023-08–2026-08)
Key numbers · FY ended 2025-12

Full financial history and reports →

Open the price chart on TradingView.

Latest filings

All filings →

Major holders (5%+) · 1
HolderStakeChangeFiled
TSURUKAME CO., LTD16.75%-1.27pp2024-07-31

Each holder's own ratio from its most recent large-shareholding report.